Cue Biopharma, Inc. (CUE) Net income 2017–2025
Cue Biopharma, Inc. (CUE) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$26.6MFY2025 · since FY2017: -$23.2M → -$26.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$26.6M | +34.6% |
| FY2024 | -$40.7M | +19.8% |
| FY2023 | -$50.7M | +4.3% |
| FY2022 | -$53.0M | -20.0% |
| FY2021 | -$44.2M | +1.4% |
| FY2020 | -$44.8M | -22.0% |
| FY2019 | -$36.7M | +5.9% |
| FY2018 | -$39.0M | -67.8% |
| FY2017 | -$23.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice